Institutional investors purchased a net $3.5 million shares of GNCA during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 14.10% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF PARTNERS LP Bought 5.0 Million shares of Genocea Biosciences Inc